GB1268469A - Halomethylquinolylamino-benzamides - Google Patents
Halomethylquinolylamino-benzamidesInfo
- Publication number
- GB1268469A GB1268469A GB3344670A GB3344670A GB1268469A GB 1268469 A GB1268469 A GB 1268469A GB 3344670 A GB3344670 A GB 3344670A GB 3344670 A GB3344670 A GB 3344670A GB 1268469 A GB1268469 A GB 1268469A
- Authority
- GB
- United Kingdom
- Prior art keywords
- alkyl
- formula
- compound
- acid addition
- reacting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229940054066 benzamide antipsychotics Drugs 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 239000002253 acid Substances 0.000 abstract 2
- -1 pyrrolidino, piperidino, hexamethyleneimino, morpholino, piperazino Chemical group 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 229910000102 alkali metal hydride Inorganic materials 0.000 abstract 1
- 150000008046 alkali metal hydrides Chemical class 0.000 abstract 1
- 150000001350 alkyl halides Chemical class 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 230000000049 anti-anxiety effect Effects 0.000 abstract 1
- 230000003276 anti-hypertensive effect Effects 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
- A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84873969A | 1969-08-08 | 1969-08-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1268469A true GB1268469A (en) | 1972-03-29 |
Family
ID=25304142
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB3344670A Expired GB1268469A (en) | 1969-08-08 | 1970-07-09 | Halomethylquinolylamino-benzamides |
Country Status (6)
Country | Link |
---|---|
BE (1) | BE754587A (enrdf_load_stackoverflow) |
BR (1) | BR6915179D0 (enrdf_load_stackoverflow) |
DE (1) | DE2034640C3 (enrdf_load_stackoverflow) |
FR (1) | FR2068477B1 (enrdf_load_stackoverflow) |
GB (1) | GB1268469A (enrdf_load_stackoverflow) |
NL (1) | NL166018C (enrdf_load_stackoverflow) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4735952A (en) * | 1985-02-11 | 1988-04-05 | Fujisawa Pharmaceutical Co., Ltd. | Arylthio piperidinamide of (4-quinolinylamino)benzoic acid and S-oxidized derivatives |
US8445516B2 (en) | 2004-01-29 | 2013-05-21 | Otsuka Pharmaceutical Co., Ltd. | Pharmaceutical composition for promoting angiogenesis |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1416872A (en) * | 1972-03-10 | 1975-12-10 | Wyeth John & Brother Ltd | 4-aminoquinoline derivatives |
FR2228482B1 (enrdf_load_stackoverflow) * | 1973-05-11 | 1976-05-14 | Roussel Uclaf | |
ZA743269B (en) * | 1973-06-15 | 1975-05-28 | Upjohn Co | Anti-hypertensive compounds |
AU674207B2 (en) * | 1993-04-07 | 1996-12-12 | Otsuka Pharmaceutical Co., Ltd. | N-acylated 4-amino piperidine derivatives |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR7870M (enrdf_load_stackoverflow) * | 1968-11-08 | 1970-04-27 |
-
0
- BE BE754587D patent/BE754587A/xx not_active IP Right Cessation
-
1969
- 1969-12-15 BR BR21517969A patent/BR6915179D0/pt unknown
-
1970
- 1970-07-09 GB GB3344670A patent/GB1268469A/en not_active Expired
- 1970-07-13 DE DE19702034640 patent/DE2034640C3/de not_active Expired
- 1970-07-17 NL NL7010668A patent/NL166018C/xx not_active IP Right Cessation
- 1970-08-07 FR FR7029224A patent/FR2068477B1/fr not_active Expired
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4735952A (en) * | 1985-02-11 | 1988-04-05 | Fujisawa Pharmaceutical Co., Ltd. | Arylthio piperidinamide of (4-quinolinylamino)benzoic acid and S-oxidized derivatives |
US8445516B2 (en) | 2004-01-29 | 2013-05-21 | Otsuka Pharmaceutical Co., Ltd. | Pharmaceutical composition for promoting angiogenesis |
Also Published As
Publication number | Publication date |
---|---|
FR2068477A1 (enrdf_load_stackoverflow) | 1971-08-27 |
FR2068477B1 (enrdf_load_stackoverflow) | 1974-03-22 |
BR6915179D0 (pt) | 1973-02-13 |
BE754587A (fr) | 1971-02-08 |
NL166018B (nl) | 1981-01-15 |
NL7010668A (enrdf_load_stackoverflow) | 1971-02-10 |
DE2034640C3 (de) | 1980-06-12 |
DE2034640B2 (enrdf_load_stackoverflow) | 1979-09-27 |
NL166018C (nl) | 1981-06-15 |
DE2034640A1 (de) | 1971-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1294763A (en) | 3-oxo-2,3-dihydro-1,4-benzoxazine derivatives | |
GB1337280A (en) | 5-phenyl-isoxazole-3-carboxylic acids and their derivatives | |
GB1239029A (enrdf_load_stackoverflow) | ||
GB1268469A (en) | Halomethylquinolylamino-benzamides | |
GB1456627A (en) | Pyridobenzodiazepinones | |
GB1187259A (en) | New Aminoalkyl Esters of 2-Anilino-Nicotinic Acids and process for their manufacture | |
GB1198688A (en) | Pyrazinoylguanidines | |
GB1384035A (en) | Amino alkyl esters of 2-anilino nicotinic acid and their preparation | |
GB1316894A (en) | Benzimidazole derivatives | |
GB1449802A (en) | Piperazine derivatives and compositions containing them for treating parkinsons disease | |
GB1394757A (en) | Lysino-calcium chloride | |
GB1181967A (en) | Novel Picoline Derivatives and a Method for the Production Thereof | |
GB1514225A (en) | Paracetamol derivatives | |
GB1281433A (en) | Allene polymines and manufacture thereof | |
GB1239567A (enrdf_load_stackoverflow) | ||
GB1245155A (en) | NOVEL 5-SUBSTITUTED-gamma-CARBOLINE DERIVATIVES AND THE SALTS THEREOF | |
GB1213285A (en) | Substituted s-triazines | |
GB1175907A (en) | Substituted Pteridine Derivatives | |
ES291187A1 (es) | Un procedimiento para preparar piperazinas sustituidas | |
GB1268454A (en) | Basic ethers and thioethers, the preparation thereof, and pharmaceutical compositions containing them | |
GB1221407A (en) | 0,2,3,4-tetrahydro-7-substituted-6-sulfamyl-4-quinazolinones, process for preparing the same and pharmaceutical compositions comprising the same | |
GB1161915A (en) | Pharmaceutical Preparations comprising Sulphur-Containing Amino-Compounds for the Treatment of Depressive Conditions | |
GB1254270A (en) | Benzoxazepine derivatives | |
GB1411782A (en) | Piperidine derivatives | |
GB1339010A (en) | Tetrazolyl-anthraquinone derivatives |